Abstract
The use of systemic siRNA therapeutics for RNA interference-mediated silencing of disease genes is limited by serum instability and inadequate biodistribution. We have previously reported on the EGFP gene silencing effect of chitosan/siRNA nanoparticles in the bronchoepithelium of mice lungs following intranasal delivery and improved serum stability and reduced off-targeting effects in vitro by incorporation of locked nucleic acid (LNA). In this study, we examine the pulmonary gene silencing effect of siLNAs targeting enhanced-green-fluorescent-protein (EGFP) in lung bronchoepithelium upon intravenous delivery of naked siLNAs and upon intranasal delivery of either naked siLNA or chitosan/siLNA nanoparticles. We show that naked siLNA administered intravenously efficiently reduces the EGFP protein expression. A similar effect is obtained with intranasal delivery of chitosan nanoparticles containing siLNA whereas intranasally instilled naked siLNA did not cause a knockdown.
Original language | English |
---|---|
Journal | Oligonucleotides |
Volume | 19 |
Issue | 2 |
Pages (from-to) | 163-8 |
Number of pages | 5 |
ISSN | 1545-4576 |
DOIs | |
Publication status | Published - 2009 |
Keywords
- Animals
- Bronchi
- Chitosan
- Drug Carriers
- Gene Silencing
- Green Fluorescent Proteins
- Injections, Intravenous
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Nanoparticles
- Oligonucleotides
- RNA, Small Interfering
- Respiratory Mucosa